Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response

Epilepsy and Behavior

Volumn 17, Issue 4, 2010, Pages 525-530

  Szaflarski, Jerzy P ^a,b,c   Lindsell, Christopher J ^a   Zakaria, Tarek ^a   Banks, Christi ^a   Privitera, Michael D ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c Cincinnati Epilepsy Center   (United States)

Author keywords

Electroencephalography; Idiopathic generalized epilepsies; Juvenile myoclonic epilepsy; Medication response; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; ETIRACETAM; FELBAMATE; LAMOTRIGINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; ARTICLE; DEMOGRAPHY; DISEASE CONTROL; DRUG RESPONSE; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FEMALE; FRONTAL LOBE; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCLONUS EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE; THALAMUS;

ADULT; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSY, GENERALIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 77952238641     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.02.005     Document Type: Article

References (55)

1. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489-501. Commission on Classification and Terminology of the International League against Epilepsy.
2. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399. Commission on Classification and Terminology of the International League Against Epilepsy.
3. Baykan B., Altindag E.A., Bebek N., et al. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology 2008, 70(22, Pt. 2):2123-2129.
4. Gelisse P., Genton P., Thomas P., Rey M., Samuelian J.C., Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001, 70:240-243.
5. Gilliam F., Kuzniecky R., Faught E., Black L., Carpenter G., Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997, 38:233-236.
6. Szaflarski J.P., Szaflarski M. Seizure disorders, depression, and health-related quality of life. Epilepsy Behav 2004, 5:50-57.
7. Iqbal N., Caswell H.L., Hare D.J., Pilkington O., Mercer S., Duncan S. Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: a preliminary controlled experimental video-EEG case series. Epilepsy Behav 2009, 14:516-521.
8. Berg A.T., Shinnar S., Levy S.R., Testa F.M., Smith-Rapaport S., Beckerman B. Early development of intractable epilepsy in children: a prospective study. Neurology 2001, 56:1445-1452.
9. Wolf P., Inoue Y. Therapeutic response of absence seizures in patients of an epilepsy clinic for adolescents and adults. J Neurol 1984, 231:225-229.
10. Fernando-Dongas M.C., Radtke R.A., VanLandingham K.E., Husain A.M. Characteristics of valproic acid resistant juvenile myoclonic epilepsy. Seizure 2000, 9:385-388.
11. Ollivier M.L., Dubois M.F., Krajinovic M., Cossette P., Carmant L. Risk factors for valproic acid resistance in childhood absence epilepsy. Seizure 2009, 18:690-694.
12. Panayiotopoulos C.P., Chroni E., Daskalopoulos C., Baker A., Rowlinson S., Walsh P. Typical absence seizures in adults: clinical, EEG, video-EEG findings and diagnostic/syndromic considerations. J Neurol Neurosurg Psychiatry 1992, 55:1002-1008.
13. Sadleir L.G., Scheffer I.E., Smith S., Connolly M.B., Farrell K. Automatisms in absence seizures in children with idiopathic generalized epilepsy. Arch Neurol 2009, 66:729-734.
14. Sadleir L.G., Farrell K., Smith S., Connolly M.B., Scheffer I.E. Electroclinical features of absence seizures in childhood absence epilepsy. Neurology 2006, 67:413-418.
15. Sadleir L.G., Scheffer I.E., Smith S., Carstensen B., Farrell K., Connolly M.B. EEG features of absence seizures in idiopathic generalized epilepsy: impact of syndrome, age, and state. Epilepsia 2009, 50:1572-1578.
16. Marson A.G., Al-Kharusi A.M., Alwaidh M., et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007, 369:1016-1026.
17. Arain A., Shihabuddin B., Niaz F., et al. Epilepsy and the impact of an epileptology clinic for patients with mental retardation and associated disabilities in an institutional setting. Epilepsia 2006, 47:2052-2057.
18. Szaflarski J.P., Rackley A.Y., Lindsell C.J., Szaflarski M., Yates S.L. Seizure control in patients with epilepsy: the physician vs medication factors. BMC Health Serv Res 2008, 8:264.
19. Szaflarski J, Difrancesco M, Hirschauer T, et al. Cortical and subcortical contributions to absence seizure onset examined with EEG/fMRI. Epilepsy Behav Submitted for publication.
20. Leutmezer F., Lurger S., Baumgartner C. Focal features in patients with idiopathic generalized epilepsy. Epilepsy Res 2002, 50:293-300.
21. Porter R.J., Penry J.K. Responsiveness at the onset of spike-wave bursts. Electroencephalogr Clin Neurophysiol 1973, 34:239-245.
22. Sadleir L. The Electro-Clinical Features of Typical Absence Seizures in Untreated Children. [Doctorate Thesis]. Wellington, New Zealand: University of Otago; 2005.
23. Blume W., Kaibara M. Atlas of adult electroencephalography 1995, Raven Press, New York.
24. Panayiotopoulos C. A clinical guide to epileptic syndromes and their treatment 2002, Bladon Medical, Chipping Norton.
25. Benbadis S.R., Tatum W.O.t., Gieron M. Idiopathic generalized epilepsy and choice of antiepileptic drugs. Neurology 2003, 61:1793-1795.
26. Genton P., Gelisse P., Thomas P., Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?. Neurology 2000, 55:1106-1109.
27. Andermann F., Berkovic S.F. Idiopathic generalized epilepsy with generalized and other seizures in adolescence. Epilepsia 2001, 42:317-320.
28. Moeller F., Siebner H.R., Wolff S., et al. Simultaneous EEG-fMRI in drug-naive children with newly diagnosed absence epilepsy. Epilepsia 2008, 49:1510-1519.
29. Aghakhani Y., Bagshaw A.P., Benar C.G., et al. FMRI activation during spike and wave discharges in idiopathic generalized epilepsy. Brain 2004, 127(Pt. 5):1127-1144.
30. Stefan H, Paulini-Ruf A, Hopfengartner R, Rampp S. Network characteristics of idiopathic generalized epilepsies in combined MEG/EEG. Epilepsy Res 2009 Apr 24.
31. Nicolson A., Appleton R.E., Chadwick D.W., Smith D.F. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry 2004, 75:75-79.
32. Ng M., Devinsky O. Vagus nerve stimulation for refractory idiopathic generalised epilepsy. Seizure 2004, 13:176-178.
33. Prasad A., Kuzniecky R.I., Knowlton R.C., et al. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol 2003, 60:1100-1105.
34. Mattson R.H., Cramer J.A., Collins J.F. For the Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992, 327:765-771.
35. Niedermeyer E., Laws E.R., Walker E.A. Depth EEG findings in epileptics with generalized spike-wave complexes. Arch Neurol 1969, 21:51-58.
36. Smith M.C. The utility of magnetoencephalography in the evaluation of secondary bilateral synchrony: a case report. Epilepsia 2004, 45(Suppl. 4):57-60.
37. Gardiner M. Genetics of idiopathic generalized epilepsies. Epilepsia 2005, 46(Suppl. 9):15-20.
38. Delgado-Escueta A.V., Greenberg D., Weissbecker K., et al. Gene mapping in the idiopathic generalized epilepsies: juvenile myoclonic epilepsy, childhood absence epilepsy, epilepsy with grand mal seizures, and early childhood myoclonic epilepsy. Epilepsia 1990, 31(Suppl. 3):S19-S29.
39. Durner M., Keddache M.A., Tomasini L., et al. Genome scan of idiopathic generalized epilepsy: evidence for major susceptibility gene and modifying genes influencing the seizure type. Ann Neurol 2001, 49:328-335.
40. Panayiotopoulos C. Juvenile myoclonic epilepsy: an autosomal recessive disease. Ann Neurol 1989, 25:440-443.
41. Greenberg D.A., Cayanis E., Strug L., et al. Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy. Am J Hum Genet 2005, 76:139-146.
42. Devinsky O., Gershengorn J., Brown E., Perrine K., Vazquez B., Luciano D. Frontal functions in juvenile myoclonic epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 1997, 10:243-246.
43. Swartz B.E., Delgado-Escueta A.V., Walsh G.O., et al. Surgical outcomes in pure frontal lobe epilepsy and foci that mimic them. Epilepsy Res 1998, 29:97-108.
44. 18FDG-PET study of dysfunctional zones. Neurology 1996, 46:737-747.
45. 18FDG-positron emission tomography in normal controls and subjects with epilepsy. Life Sci 1996, 58:2057-2064.
46. 18FDG-positron emission tomography scans in frontal and " frontal plus" epilepsy. Epilepsia 1995, 36:388-395.
47. Woermann F.G., Sisodiya S., Free S., Duncan J.S. Quantitative MRI in patients with idiopathic generalized epilepsy: evidence of widespread cerebral structural changes. Brain 1998, 121:1661-1667.
48. Woermann F.G., Free S., Koepp M., Sisodiya S., Duncan J.S. Abnormal cerebral structure in juvenile myoclonic epilepsy demonstrated with voxel-based analysis of MRI. Brain 1999, 122:2101-2107.
49. Woermann F.G., Free S., Koepp M., Ashburner J., Duncan J.S. Voxel-by-voxel comparison of automatically segmented cerebral gray matter: a rater-independent comparison of structural MRI in patients with epilepsy. NeuroImage 1999, 10:373-384.
50. Meencke H.J., Janz D. Neuropathological findings in primary generalized epilepsy: a study of eight cases. Epilepsia 1984, 25:8-21.
51. Meencke H.J., Janz D. The significance of microdysgenesia in primary generalized epilepsy: an answer to the considerations of Lyon and Gastaut. Epilepsia 1985, 26:368-371.
52. De Araujo Filho G.M., Pascalicchio T.F., Sousa Pda S., Lin K., Ferreira Guilhoto L.M., Yacubian E.M. Psychiatric disorders in juvenile myoclonic epilepsy: a controlled study of 100 patients. Epilepsy Behav 2007, 10:437-441.
53. Sonmez F., Atakli D., Sari H., Atay T., Arpaci B. Cognitive function in juvenile myoclonic epilepsy. Epilepsy Behav 2004, 5:329-336.
54. Doval O., Gaviria M., Kanner A. Frontal lobe dysfunction in epilepsy. Psychiatric issues in epilepsy 2001, 261-272. Lippincott, Williams & Wilkins, Philadelphia. A. Ettinger, A. Kanner (Eds.).
55. Stuss D.T., Gow C.A., Hetherington C.R. " No longer Gage": frontal lobe dysfunction and emotional changes. J Consult Clin Psychol 1992, 60:349-359.